ongoing clinical trials with parp inhibitors in ovarian cancer
Published 9 years ago • 1.1K plays • Length 18:37Download video MP4
Download video MP3
Similar videos
-
15:43
clinical data with parp inhibitors in ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
39:25
navigating rapid change in ovarian cancer: parp inhibitors in clinical pathways
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
50:21
parp inhibitor therapy for ovarian cancer: practical prescribing and medication management
-
17:35
expert perspectives: the clinical potential of parp inhibitors in ovarian cancer
-
29:51
evaluating clinical pathways for ovarian cancer treatment and maintenance therapy
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
53:54
parp inhibitors in ovarian cancer treatment | webinar | ambry genetics
-
0:45
evaluating future use of parp inhibitors in neoadjuvant therapy for ovarian cancer
-
1:38
updates in parp inhibition for ovarian cancer
-
1:23:55
the clinical potential of novel parp inhibitors for improved management of epithelial ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
1:10:07
optimizing the use of parp inhibitors in ovarian cancer
-
1:26
parp inhibitors for maintenance therapy in ovarian cancer
-
28:24
chair's take: latest and emerging evidence of parp inhibitors in ovarian cancer management
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer